- Home
- CODA vs VIGL Comparison
CODA vs VIGL Comparison
Compare CODA & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- VIGL
- Stock Information
- Founded
- CODA 1994
- VIGL 2020
- Country
- CODA United States
- VIGL United States
- Employees
- CODA N/A
- VIGL N/A
- Industry
- CODA Industrial Machinery/Components
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- VIGL Health Care
- Exchange
- CODA Nasdaq
- VIGL Nasdaq
- Market Cap
- CODA 88.7M
- VIGL 134.9M
- IPO Year
- CODA N/A
- VIGL 2022
- Fundamental
- Price
- CODA $8.49
- VIGL $8.07
- Analyst Decision
- CODA Strong Buy
- VIGL Buy
- Analyst Count
- CODA 1
- VIGL 7
- Target Price
- CODA $11.00
- VIGL $8.00
- AVG Volume (30 Days)
- CODA 49.8K
- VIGL 798.1K
- Earning Date
- CODA 06-16-2025
- VIGL 08-12-2025
- Dividend Yield
- CODA N/A
- VIGL N/A
- EPS Growth
- CODA 21.86
- VIGL N/A
- EPS
- CODA 0.30
- VIGL N/A
- Revenue
- CODA $22,758,966.00
- VIGL N/A
- Revenue This Year
- CODA $30.82
- VIGL N/A
- Revenue Next Year
- CODA $20.84
- VIGL N/A
- P/E Ratio
- CODA $28.49
- VIGL N/A
- Revenue Growth
- CODA 24.78
- VIGL N/A
- 52 Week Low
- CODA $5.76
- VIGL $1.31
- 52 Week High
- CODA $9.89
- VIGL $8.11
- Technical
- Relative Strength Index (RSI)
- CODA 61.02
- VIGL 89.08
- Support Level
- CODA $7.86
- VIGL $8.03
- Resistance Level
- CODA $8.50
- VIGL $8.05
- Average True Range (ATR)
- CODA 0.35
- VIGL 0.03
- MACD
- CODA -0.01
- VIGL -0.12
- Stochastic Oscillator
- CODA 75.39
- VIGL 86.73
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.